Manuel Saenz-de-Viteri1,2, Tomas Cudrnak1. Show Affiliations » 1. a Royal Eye Infirmary , University Hospitals Plymouth , Plymouth , United Kingdom. 2. b Department of Ophthalmology , University of Navarra , Pamplona , Spain.
Abstract
Entities: Chemical Disease Species
Mesh： See more » AgedAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useHumansLeukemia, Lymphocytic, Chronic, B-Cell/complicationsLeukemia, Lymphocytic, Chronic, B-Cell/diagnosisLeukemia, Lymphocytic, Chronic, B-Cell/drug therapyLeukemia, Lymphocytic, Chronic, B-Cell/etiologyMacular Edema/diagnosisMacular Edema/etiologyMaleProtein Kinase Inhibitors/adverse effectsProtein Kinase Inhibitors/therapeutic usePyrazoles/adverse effectsPyrazoles/therapeutic usePyrimidines/adverse effectsPyrimidines/therapeutic useTomography, Optical Coherence
Substances： See more » Antineoplastic AgentsProtein Kinase InhibitorsPyrazolesPyrimidinesibrutinib
Year: 2018 PMID： 30188238 DOI： 10.1080/10428194.2018.1508673
Source DB: PubMed Journal: Leuk Lymphoma ISSN： 1026-8022